eflornithine has been researched along with Congenital Zika Syndrome in 2 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Mounce, BC | 1 |
| Cesaro, T | 1 |
| Moratorio, G | 1 |
| Hooikaas, PJ | 1 |
| Yakovleva, A | 1 |
| Werneke, SW | 1 |
| Smith, EC | 1 |
| Poirier, EZ | 1 |
| Simon-Loriere, E | 1 |
| Prot, M | 1 |
| Tamietti, C | 1 |
| Vitry, S | 1 |
| Volle, R | 1 |
| Khou, C | 1 |
| Frenkiel, MP | 1 |
| Sakuntabhai, A | 1 |
| Delpeyroux, F | 1 |
| Pardigon, N | 1 |
| Flamand, M | 1 |
| Barba-Spaeth, G | 1 |
| Lafon, M | 1 |
| Denison, MR | 1 |
| Albert, ML | 1 |
| Vignuzzi, M | 1 |
2 other studies available for eflornithine and Congenital Zika Syndrome
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.
Topics: Acetyltransferases; Animals; Antiviral Agents; Cell Line; Chikungunya Fever; Chikungunya virus; Dise | 2016 |